erythromycin has been researched along with carbamazepine in 66 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (42.42) | 18.7374 |
1990's | 8 (12.12) | 18.2507 |
2000's | 8 (12.12) | 29.6817 |
2010's | 18 (27.27) | 24.3611 |
2020's | 4 (6.06) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Li, YH; Wang, YH; Yang, L; Yang, SL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Claris-Appiani, A; Giani, M; Romeo, A; Rossi, LN; Viani, F | 1 |
Andersson, P; Jensen, PK; Jolkkonen, J; Keränen, T; Menge, GP | 1 |
Hopkins, S | 1 |
Edis, RH; Ng, K; Silbert, PL | 1 |
Mitsch, RA | 1 |
Itagaki, T; Mimaki, T; Ono, J; Suzuki, Y; Tagawa, T; Tanaka, J; Yabuuchi, H | 1 |
Renton, KW; Turner, PV | 1 |
Goldhoorn, PB; Hofstee, N | 1 |
Raasch, RH | 1 |
Miles, MV; Tennison, MB | 1 |
Baciewicz, AM | 1 |
Bolyard, KJ; Kearns, GL; Woody, RC | 1 |
Albin, H; Guyot, M; Loiseau, P; Pautrizel, B; Vincon, G | 1 |
Adkins, WN; Berg, J; Burstyn, DG; Davis, JP; Hopfensperger, D; Manclark, CR; Schell, WL; Steketee, RW; Wassilak, SG | 1 |
Debreczeni, LA; Herjavecz, I; Szeitz, A | 1 |
Amione, C; Barzaghi, N; Crema, F; Faja, A; Gatti, G; Leone, L; Monteleone, M; Perucca, E | 1 |
Bruni, O; Curatolo, P; Cusmai, R | 1 |
Amione, C; Barzaghi, N; Crema, F; Gatti, G; Leone, L; Monteleone, M; Perucca, E | 1 |
Adderly, RJ; D'Orsogna, L; Macnab, AJ; Robinson, JL | 1 |
Camfield, P; Dooley, JM; Fraser, A; Goulden, KJ; Meek, DC; Renton, KW; Tibbles, JA | 1 |
Altman, H; Howrie, DL; Maroon, TJ; Zitelli, BJ | 1 |
André, P; Descotes, J; Evreux, JC | 1 |
Singer, WD; Whyte, J; Wroblewski, BA | 1 |
Berrettini, WH | 1 |
Abbas, D; Jaster, PJ | 1 |
Al-Rajeh, S; Carranco, E; Co, S; Kareus, J; Peak, V | 1 |
Kessler, JM | 1 |
Cate, JC; Hedrick, R; Lamb, WA; Morin, R; Williams, F | 1 |
Bladin, PF; Vajda, FJ | 1 |
D'Arcy, PF | 1 |
Bell, RD; Ludden, TM; Wong, YY | 1 |
Straughan, J | 1 |
Boustany, RM; DeLong, GR; Loganbill, H; Nahouraii, R; Nohria, V; Stafstrom, CE | 1 |
Patterson, BD | 1 |
Carvalho, C; Ferreira, P; Mota, C; Mota, CR; Pereira, E; Vilarinho, A | 1 |
Hirayama, F; Iizumi, Y; Kawasaki, T; Koshio, H; Matsumoto, Y; Sato, K; Taniuchi, Y | 1 |
Ariyoshi, N; Igarashi, T; Ishii, I; Kitada, M; Nakamura, H; Nakasa, H; Ohmori, S | 1 |
Correia, MA; Kang, P; Leeder, JS; Liao, M; Pearce, RE; Wester, MR | 1 |
Chen, F; Chen, H; Fu, W; Luo, W; Meng, F; Xie, Y; Yang, X; Ye, T; Young, K | 1 |
Barcellini-Couget, S; de Sousa, G; Luzy, AP; Peyre, L; Rahmani, R; Zucchini-Pascal, N | 1 |
Almeida, CM; Benoliel, MJ; Cardoso, VV; de Jesus Gaffney, V; Loureiro, M; Mota-Filipe, H; Pinto, RA; Thiemermann, C | 1 |
De Guise, S; Fortier, M; Fournier, M; Hammill, M; Kleinert, C; Lacaze, E | 1 |
Fang, TH; Kao, CH; Lin, CW | 1 |
Bianco, G; Bufo, SA; Caniani, D; Coviello, D; Cristina Lafiosca, M; Mancini, IM; Masi, S; Pascale, R; Scrano, L | 1 |
Cao, X; Lu, Y; Song, S; Wang, C; Xiu, C; Zhang, M | 1 |
Alsubih, M; Balakrishnan, D; El Morabet, R; Khan, AR; Khan, NA; Khan, RA; Khan, S; Khoo, KS; Mubashir, M | 1 |
Cai, TG; Cui, HL; Liu, ZL; Qiao, M; Wang, YF; Zhu, D | 1 |
3 review(s) available for erythromycin and carbamazepine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Carbamazepine drug interactions.
Topics: Carbamazepine; Cimetidine; Dextropropoxyphene; Drug Interactions; Erythromycin; Humans; Isoniazid; Lithium; Phenobarbital; Phenytoin; Primidone; Protein Binding; Troleandomycin; Valproic Acid; Warfarin | 1986 |
Pharmacokinetic drug interactions with macrolide antibiotics.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antipyrine; Carbamazepine; Drug Interactions; Ergot Alkaloids; Erythromycin; Humans; Kinetics; Pharmaceutical Preparations; Theophylline; Troleandomycin | 1985 |
3 trial(s) available for erythromycin and carbamazepine
Article | Year |
---|---|
Absence of interaction between oxcarbazepine and erythromycin.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Female; Humans; Male; Metabolic Clearance Rate; Oxcarbazepine | 1992 |
Clinical toleration and safety of azithromycin.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Carbamazepine; Child; Child, Preschool; Cimetidine; Contraindications; Drug Evaluation; Drug Interactions; Eating; Erythromycin; Female; Humans; Male; Methylprednisolone; Middle Aged; Respiratory Tract Infections; Skin Diseases, Infectious; Theophylline; Urethritis; Uterine Cervicitis | 1991 |
Inhibition by erythromycin of the conversion of carbamazepine to its active 10,11-epoxide metabolite.
Topics: Adult; Biotransformation; Carbamazepine; Depression, Chemical; Erythromycin; Humans; Male | 1987 |
60 other study(ies) available for erythromycin and carbamazepine
Article | Year |
---|---|
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
Topics: Computational Biology; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Molecular Structure; Principal Component Analysis; Pyrrolizidine Alkaloids; Quantitative Structure-Activity Relationship; Reproducibility of Results; Substrate Specificity; Venlafaxine Hydrochloride | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Severe hepatorenal failure in a child receiving carbamazepine and erythromycin.
Topics: Carbamazepine; Chemical and Drug Induced Liver Injury; Child; Erythromycin; Humans; Kidney Tubular Necrosis, Acute; Male | 1992 |
Complete external ophthalmoplegia and asterixis with carbamazepine toxicity.
Topics: Carbamazepine; Drug Interactions; Drug Overdose; Erythromycin; Female; Humans; Middle Aged; Ophthalmoplegia; Posture; Tremor | 1991 |
Carbamazepine toxicity precipitated by intravenous erythromycin.
Topics: Adult; Carbamazepine; Drug Interactions; Erythromycin; Humans; Injections, Intravenous; Male | 1989 |
Erythromycin-induced carbamazepine intoxication in two epileptic children.
Topics: Carbamazepine; Child; Common Cold; Drug Therapy, Combination; Epilepsy, Temporal Lobe; Erythromycin; Female; Humans; Male; Seizures, Febrile; Tooth Diseases | 1989 |
The interaction between carbamazepine and erythromycin.
Topics: Animals; Carbamazepine; Drug Interactions; Erythromycin; Female; Half-Life; In Vitro Techniques; Male; Microsomes, Liver; Rats; Rats, Inbred Strains; Swine | 1989 |
[Interaction between erythromycin and carbamazepine].
Topics: Carbamazepine; Cerebellar Ataxia; Drug Interactions; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Myoclonic Cerebellar Dyssynergia; Respiratory Tract Infections | 1989 |
Interactions of oral antibiotics and common chronic medications.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Aged; Allopurinol; Ampicillin; Antacids; Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Digoxin; Drug Combinations; Drug Interactions; Erythromycin; Humans; Sulfamethoxazole; Sulfonamides; Sulfonylurea Compounds; Tetracycline; Theophylline; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Warfarin | 1987 |
Erythromycin effects on multiple-dose carbamazepine kinetics.
Topics: Absorption; Adult; Carbamazepine; Drug Interactions; Erythromycin; Humans; Male | 1989 |
Carbamazepine intoxication following the use of erythromycin in children.
Topics: Adolescent; Carbamazepine; Child, Preschool; Drug Interactions; Drug Therapy, Combination; Epilepsies, Partial; Erythromycin; Female; Humans; Otitis Externa; Otitis Media | 1987 |
[Carbamazepine poisoning caused by carbamazepine-erythromycin interaction].
Topics: Adult; Carbamazepine; Drug Interactions; Erythromycin; Female; Humans | 1985 |
Evidence for a high attack rate and efficacy of erythromycin prophylaxis in a pertussis outbreak in a facility for the developmentally disabled.
Topics: Adolescent; Adult; Carbamazepine; Child; Child, Preschool; Diphtheria Toxoid; Diphtheria-Tetanus-Pertussis Vaccine; Disease Outbreaks; Drug Combinations; Drug Interactions; Erythromycin; Humans; Infant; Institutionalization; Intellectual Disability; Middle Aged; Pertussis Vaccine; Tetanus Toxoid; Whooping Cough | 1988 |
Effects of drugs on aminophylline elimination in rats.
Topics: Aminophylline; Animals; Behavior, Animal; Carbamazepine; Cimetidine; Drug Combinations; Drug Interactions; Erythromycin; Female; Half-Life; Phenobarbital; Phenytoin; Rats; Rats, Inbred Strains; Rifampin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Effect of flurithromycin, a new macrolide antibiotic, on carbamazepine disposition in normal subjects.
Topics: Adult; Carbamazepine; Erythromycin; Half-Life; Humans; Male | 1988 |
Use of erythromycin to inhibit carbamazepine metabolism in children with partial complex seizures.
Topics: Carbamazepine; Child; Child, Preschool; Drug Interactions; Epilepsy, Temporal Lobe; Erythromycin; Humans | 1988 |
Heart block secondary to erythromycin-induced carbamazepine toxicity.
Topics: Carbamazepine; Child; Drug Interactions; Erythromycin; Heart Arrest; Heart Block; Humans; Male | 1987 |
Severe carbamazepine intoxication after coadministration of erythromycin.
Topics: Carbamazepine; Child; Child, Preschool; Drug Interactions; Erythromycin; Female; Half-Life; Humans; Infant; Male; Time Factors | 1986 |
Erythromycin-induced drug interactions. An illustrative case and review of the literature.
Topics: Carbamazepine; Child; Cyclosporins; Digoxin; Drug Interactions; Erythromycin; Female; Humans; Metabolic Clearance Rate; Theophylline; Warfarin | 1987 |
Carbamazepine-erythromycin interaction. Case studies and clinical significance.
Topics: Adult; Carbamazepine; Drug Interactions; Erythromycin; Female; Fluorescence Polarization; Humans; Male | 1986 |
A case of erythromycin-induced carbamazepine toxicity.
Topics: Adult; Bipolar Disorder; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Erythromycin; Female; Humans; Sinusitis | 1986 |
Erythromycin-carbamazepine interaction.
Topics: Adult; Ataxia; Carbamazepine; Dizziness; Drug Interactions; Erythromycin; Female; Humans; Male; Sleep Stages; Speech Disorders | 1986 |
Carbamazepine toxicity induced by concurrent erythromycin therapy.
Topics: Adult; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Erythromycin; Female; Humans; Inappropriate ADH Syndrome | 1985 |
Erythromycin-carbamazepine interaction.
Topics: Carbamazepine; Child; Drug Interactions; Erythromycin; Female; Humans | 1985 |
Carbamazepine--erythromycin interaction leading to carbamazepine toxicity in four epileptic children.
Topics: Carbamazepine; Child; Child, Preschool; Drug Interactions; Epilepsy; Erythromycin; Female; Humans; Infant; Male; Phenobarbital | 1983 |
Carbamazepine--erythromycin-base interaction.
Topics: Adult; Carbamazepine; Drug Interactions; Epilepsy; Erythromycin; Female; Humans | 1984 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
Effect of erythromycin on carbamazepine kinetics.
Topics: Adult; Carbamazepine; Chromatography, High Pressure Liquid; Drug Interactions; Erythromycin; Humans; Kinetics; Male; Random Allocation | 1983 |
Erythromycin-carbamazepine interaction?
Topics: Carbamazepine; Child; Drug Interactions; Erythromycin; Humans | 1982 |
Erythromycin-induced carbamazepine toxicity: a continuing problem.
Topics: Adolescent; Carbamazepine; Child; Child, Preschool; Clarithromycin; Drug Interactions; Epilepsy; Erythromycin; Female; Humans; Male | 1995 |
Possible interaction between metronidazole and carbamazepine.
Topics: Bipolar Disorder; Carbamazepine; Drug Interactions; Erythromycin; Female; Humans; Metronidazole; Middle Aged | 1994 |
Severe carbamazepine toxicity induced by concurrent erythromycin therapy.
Topics: Anti-Bacterial Agents; Anticonvulsants; Carbamazepine; Child; Drug Interactions; Drug Therapy, Combination; Epilepsy; Erythromycin; Humans; Male; Pharyngitis | 1996 |
Comparison of the anticoagulant and antithrombotic effects of YM-75466, a novel orally-active factor Xa inhibitor, and warfarin in mice.
Topics: Administration, Oral; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Anticoagulants; Anticonvulsants; Antifibrinolytic Agents; Blood Coagulation; Carbamazepine; Cimetidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Erythromycin; Factor Xa Inhibitors; Fibrinolytic Agents; Hemorrhage; Male; Mice; Mice, Inbred ICR; Partial Thromboplastin Time; Phenytoin; Piperidines; Prothrombin Time; Rifampin; Sulfonamides; Thromboembolism; Thromboplastin; Vitamin K 1; Warfarin | 1998 |
Effects of endogenous steroids on CYP3A4-mediated drug metabolism by human liver microsomes.
Topics: Adult; Carbamazepine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Epoxy Compounds; Erythromycin; Humans; Hydroxylation; In Vitro Techniques; Isoxazoles; Kinetics; Microsomes, Liver; Mixed Function Oxygenases; Nevirapine; Pharmaceutical Preparations; Phenols; Steroids; Sulfonamides; Triazolam; Zonisamide | 2002 |
CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile.
Topics: Carbamazepine; Crystallography, X-Ray; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Enzyme Activation; Erythromycin; Humans; Kinetics; Methylation; Models, Molecular; Protein Binding; Recombinant Proteins; Steroid Hydroxylases; Testosterone | 2008 |
Occurrence and fate of PPCPs and correlations with water quality parameters in urban riverine waters of the Pearl River Delta, South China.
Topics: Acetaminophen; Caffeine; Carbamazepine; Carbon; China; Ciprofloxacin; DEET; Environmental Monitoring; Erythromycin; Nitrates; Nitrites; Nitrogen; Pharmaceutical Preparations; Quaternary Ammonium Compounds; Rivers; Sulfamethoxazole; Trimethoprim; Water Pollutants, Chemical; Water Quality | 2013 |
High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity.
Topics: Acetaminophen; Amodiaquine; Animals; Carbamazepine; Cell Line, Tumor; Cell Survival; Cells, Cultured; Chemical and Drug Induced Liver Injury; Diethylstilbestrol; Erythromycin; Furosemide; Hepatocytes; High-Throughput Screening Assays; Male; Neutral Red; Rats; Toxicity Tests; Tretinoin | 2015 |
Chemical and biochemical characterization and in vivo safety evaluation of pharmaceuticals in drinking water.
Topics: Animals; Caffeine; Carbamazepine; Chromatography, High Pressure Liquid; Drinking Water; Environmental Exposure; Erythromycin; Kidney; Liver; Models, Theoretical; Pharmaceutical Preparations; Rats; Rats, Wistar; Tandem Mass Spectrometry; Water Purification | 2016 |
T lymphocyte-proliferative responses of harbor seal (Phoca vitulina) peripheral blood mononuclear cells (PBMCs) exposed to pharmaceuticals in vitro.
Topics: Animals; Carbamazepine; Cell Proliferation; Erythromycin; Ethinyl Estradiol; Female; Leukocytes, Mononuclear; Male; Naproxen; Phoca; T-Lymphocytes; Water Pollutants, Chemical | 2018 |
Occurrence and distribution of pharmaceutical compounds in the Danshuei River Estuary and the Northern Taiwan Strait.
Topics: Aquatic Organisms; Carbamazepine; Environmental Monitoring; Erythromycin; Estuaries; Gemfibrozil; Pharmaceutical Preparations; Rivers; Seawater; Taiwan; Water Pollutants, Chemical | 2019 |
Validation of a liquid chromatography coupled with tandem mass spectrometry method for the determination of drugs in wastewater using a three-phase solvent system.
Topics: Amoxicillin; Carbamazepine; Chromatography, Liquid; Clarithromycin; Erythromycin; Metformin; Particle Size; Solvents; Surface Properties; Tandem Mass Spectrometry; Wastewater; Water Pollutants, Chemical | 2020 |
Distribution and ecological risks of pharmaceuticals and personal care products with different anthropogenic stresses in a coastal watershed of China.
Topics: Caffeine; Carbamazepine; China; Cosmetics; Ecosystem; Environmental Monitoring; Erythromycin; Pharmaceutical Preparations; Risk Assessment; Rivers; Sulfamethoxazole; Water; Water Pollutants, Chemical | 2022 |
Comparison of constructed wetland performance coupled with aeration and tubesettler for pharmaceutical compound removal from hospital wastewater.
Topics: Acetaminophen; Animals; Carbamazepine; Ciprofloxacin; Erythromycin; Hospitals; Ibuprofen; Lorazepam; Pharmaceutical Preparations; Simvastatin; Waste Disposal, Fluid; Wastewater; Wetlands | 2023 |
A new insight into the potential drivers of antibiotic resistance gene enrichment in the collembolan gut association with antibiotic and non-antibiotic agents.
Topics: Animals; Anti-Bacterial Agents; Arthropods; Carbamazepine; Drug Resistance, Microbial; Erythromycin; Genes, Bacterial; Microbiota; Soil; Soil Microbiology | 2023 |